Funding for this research was provided by:
Received: 21 August 2020
Revised: 4 November 2020
Accepted: 27 November 2020
First Online: 14 February 2021
Change Date: 20 March 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00330-021-07795-z
Compliance with ethical standards
: The scientific guarantor of this publication is Bernd Hamm.
: Bernd Hamm declares relationships (institutional support) with the following companies: Abbott, Actelion Pharmaceuticals, Bayer Schering Pharma, Bayer Vital, BRACCO Group, Bristol Myers Squibb, Charité Research Organisation GmbH, Deutsche Krebshilfe, Dt. Stiftung für Herzforschung, Essex Pharma, EU Programmes (Past President of ESR), Fibrex Medical Inc., Focused Ultrasound Surgery Foundation, Fraunhofer Gesellschaft, Guerbet, INC Research, InSightec Ltd., IPSEN Pharma, Kendle/MorphoSys AG, Lilly GmbH, Lundbeck GmbH, MeVis Medical Solutions AG, Nexus Oncology, Novartis, Parexel CRO Service, Perceptive, Pfizer GmbH, Phillips, sanofi-aventis S.A., Siemens, Spectranetics GmbH, Terumo Medical Corporation, TNS Healthcare GmbH, Toshiba, UCB Pharma, Wyeth Pharma, Zukunftsfonds Berlin (TSB).Patrick Asbach declares relationships with the following companies: Siemens, b.e. ImagingMatthias Haas declares relationships with the following company: b.e. ImagingAnwar R. Padhani declares relationships with the following companies: Astellas, Bayer, Janssen, Lucida medical Ltd., Roche, Sanofi, Siemens Healthineers, MintFabian H. J. Elsholtz, Minerva Becker, Regina G. H. Beets-Tan, and Harriet C. Thoeny declare no conflicts of interest.
: No complex statistical methods were necessary for this paper.
: This was no study on human subjects. Therefore, no informed consent was necessary.
: Institutional Review Board approval was not required because the study did not include human subjects.
: • Guideline